PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
+10.72%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$94.7M
AUM Growth
+$94.7M
(+1.7%)
Cap. Flow
-$2.25M
Cap. Flow
% of AUM
-2.38%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
TRVN
Trevena, Inc.
TRVN
|
$1.46M |
| 2 |
BIND
BIND THERAPEUTICS INC
BIND
|
$789K |
Sector Composition
| 1 | Healthcare | 85.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cartesian Therapeutics
RNAC
$256M
| $27.4M | 28.95% |
1,924,151
| – | – |
|
|
TRVN
2
DELISTED
Trevena, Inc.
TRVN
| $13.9M | 14.63% |
2,053,540
-216,779
| -10% | -$1.46M |
|
|
TTOO
3
DELISTED
T2 Biosystems, Inc
TTOO
| $13.6M | 14.34% |
1,875,524
| – | – |
|
|
GNCA
4
DELISTED
Genocea Biosciences, Inc.
GNCA
| $10.1M | 10.64% |
1,968,606
| – | – |
|
5
Fate Therapeutics
FATE
$119M
| $7.72M | 8.15% |
2,473,186
| – | – |
|
6
Ocular Therapeutix
OCUL
$2.21B
| $6.86M | 7.24% |
998,713
| – | – |
|
7
Pulmatrix
PULM
$17.4M
| $5.95M | 6.28% |
3,607,996
| – | – |
|
|
ATYR
8
aTyr Pharma
ATYR
$554M
| $5.81M | 6.14% |
1,827,992
| – | – |
|
9
Dare Bioscience
DARE
$27.4M
| $3.44M | 3.63% |
3,287,529
| – | – |
|
|
BIND
10
DELISTED
BIND THERAPEUTICS INC
BIND
| – | – |
-2,018,253
| Closed | -$789K |
|